| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics, Inc. | Director | Class A Common Stock | 3,596,593 | $102,359,036 | $28.46 | 11 Dec 2025 | Indirect |
| Zenas BioPharma, Inc. | Director | Common Stock | 1,832,669 | $34,820,711 | $19.00 | 09 Oct 2025 | Indirect |
| BioAge Labs, Inc. | Director | Common Stock | 1,710,589 | $30,790,602 | $18.00 | 27 Sep 2024 | Longitude Venture Partners IV, L.P. |
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 21,379 | $3,623,976 | $169.51 | 18 Aug 2025 | Direct |
| Zenas BioPharma, Inc. | Director | Common Stock | 11,990 | $249,991 | $20.85 | 09 Oct 2025 | Direct |
| Vera Therapeutics, Inc. | Director | Class A Common Stock | 5,882 | $249,985 | $42.50 | 11 Dec 2025 | Direct |
| Veradermics, Inc | Director, 10%+ Owner | Common Stock | 2,053,474 | 05 Feb 2026 | Indirect | ||
| Veradermics, Inc | Director, 10%+ Owner | Stock Option (Right to Buy) | 45,131 | 03 Feb 2026 | Direct | ||
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40,000 | 26 May 2022 | Direct | ||
| BioAge Labs, Inc. | Director | Stock Option (Right to Buy) | 22,000 | 05 Jun 2025 | Direct | ||
| Zenas BioPharma, Inc. | Director | Stock Option (Right to Buy) | 18,500 | 10 Jun 2025 | Direct | ||
| Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14,000 | 14 May 2025 | Direct | ||
| BioAge Labs, Inc. | Director | Series D Preferred Stock | 0 | 27 Sep 2024 | Longitude Venture Partners IV, L.P. | ||
| Veradermics, Inc | Director, 10%+ Owner | Series B Convertible Preferred Stock | 0 | 05 Feb 2026 | Indirect | ||
| Veradermics, Inc | Director, 10%+ Owner | Series C Convertible Preferred Stock | 0 | 05 Feb 2026 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MANE | Veradermics, Inc | 03 Feb 2026 | 9 | +$18,275,000 | 4 | Director, 10%+ Owner | 05 Feb 2026, 19:03 |
| MANE | Veradermics, Inc | 03 Feb 2026 | 0 | $0 | 3 | Director, 10%+ Owner | 03 Feb 2026, 21:05 |
| VERA | Vera Therapeutics, Inc. | 11 Dec 2025 | 1 | +$249,985 | 4 | Director | 15 Dec 2025, 20:07 |
| ZBIO | Zenas BioPharma, Inc. | 09 Oct 2025 | 2 | +$2,250,026 | 4 | Director | 14 Oct 2025, 08:59 |
| JAZZ | Jazz Pharmaceuticals plc | 18 Aug 2025 | 1 | $0 | 4 | Director | 08 Jan 2026, 17:56 |
| JAZZ | Jazz Pharmaceuticals plc | 07 Aug 2025 | 2 | -$200,805 | 4 | Director | 11 Aug 2025, 17:46 |
| VERA | Vera Therapeutics, Inc. | 23 Jun 2025 | 4 | +$5,277,311 | 4 | Director | 25 Jun 2025, 20:07 |
| ZBIO | Zenas BioPharma, Inc. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:33 |
| BIOA | BioAge Labs, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:44 |
| VERA | Vera Therapeutics, Inc. | 14 May 2025 | 1 | $0 | 4 | Director | 16 May 2025, 16:13 |
| BIOA | BioAge Labs, Inc. | 25 Sep 2024 | 4 | +$7,200,000 | 4 | Director | 27 Sep 2024, 16:26 |
| BIOA | BioAge Labs, Inc. | 25 Sep 2024 | 0 | $0 | 3 | Director | 25 Sep 2024, 16:52 |
| ZBIO | Zenas BioPharma, Inc. | 12 Sep 2024 | 8 | +$7,480,000 | 4 | Director | 16 Sep 2024, 20:57 |
| ZBIO | Zenas BioPharma, Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director | 12 Sep 2024, 21:42 |
| JAZZ | Jazz Pharmaceuticals plc | 02 Aug 2024 | 1 | $0 | 4 | Director | 06 Aug 2024, 18:45 |
| VERA | Vera Therapeutics, Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 16:10 |
| JAZZ | Jazz Pharmaceuticals plc | 11 Aug 2023 | 2 | -$171,455 | 4 | Director | 15 Aug 2023, 17:45 |
| VERA | Vera Therapeutics, Inc. | 10 May 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 12 May 2023, 16:12 |
| VERA | Vera Therapeutics, Inc. | 06 Feb 2023 | 1 | +$11,999,995 | 4 | Director, 10%+ Owner | 08 Feb 2023, 18:32 |
| JAZZ | Jazz Pharmaceuticals plc | 22 Nov 2022 | 3 | -$1,049,264 | 4 | Director | 25 Nov 2022, 20:33 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Aug 2022 | 2 | -$165,883 | 4 | Director | 09 Aug 2022, 18:12 |
| /report/000141588922005905-enright-patrick-g-2022-05-26 | Aptinyx Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 16:30 |
| VERA | Vera Therapeutics, Inc. | 24 May 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 26 May 2022, 16:13 |
| VERA | Vera Therapeutics, Inc. | 10 Feb 2022 | 1 | +$4,999,995 | 4 | Director, 10%+ Owner | 05 Apr 2022, 07:22 |
| JAZZ | Jazz Pharmaceuticals plc | 18 Aug 2021 | 1 | +$275,500 | 4 | Director | 20 Aug 2021, 19:12 |
| JAZZ | Jazz Pharmaceuticals plc | 29 Jul 2021 | 1 | $0 | 4 | Director | 02 Aug 2021, 18:10 |
| /report/000141588921002734-enright-patrick-g-2021-05-27 | Aptinyx Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 16:31 |
| VERA | Vera Therapeutics, Inc. | 18 May 2021 | 3 | +$9,999,990 | 4 | Director, 10%+ Owner | 18 May 2021, 20:14 |
| VERA | Vera Therapeutics, Inc. | 13 May 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 17 May 2021, 20:36 |
| VERA | Vera Therapeutics, Inc. | 13 May 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 13 May 2021, 19:18 |